Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

NanoVibronix Inc (NAOV) USD0.001

Sell:$2.88 Buy:$3.10 Change: $0.03 (1.01%)
NASDAQ:0.11%
Market closed |  Prices as at close on 18 November 2019 | Switch to live prices |
Sell:$2.88
Buy:$3.10
Change: $0.03 (1.01%)
Market closed |  Prices as at close on 18 November 2019 | Switch to live prices |
Sell:$2.88
Buy:$3.10
Change: $0.03 (1.01%)
Market closed |  Prices as at close on 18 November 2019 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

NanoVibronix, Inc. is a medical device company focusing on noninvasive biological response-activating devices that target wound healing and pain therapy. The Company's products include PainShield, WoundShield and UroShield. Its products under development include Renooskin and Endotrachshield. The Company's principal research and development activities are conducted in Israel, through its subsidiary, NanoVibronix (Israel 2003) Ltd. The Company operates in the United States, Europe and India, among others. The PainShield is a disposable patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures by delivering a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area. The Company's WoundShield system is a patch-based therapeutic ultrasound device that facilitates tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation.

Contact details

Address:
525 Executive Blvd
ELMSFORD
10523-1240
United States
Telephone:
+1 (914) 2333004
Website:
www.nanovibronix.com

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
NAOV
ISIN:
US63008J1088
Market cap:
$13.16 million
Shares in issue:
4.43 million
Sector:
Health Care Equipment
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Christopher Fashek
    Chairman of the Board
  • William Stern
    President
  • Brian Murphy
    Chief Executive Officer, Director
  • James Cardwell
    Chief Financial Officer
  • Harold Jacob
    Chief Medical Officer, Director

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.